Joint Venture




The first and only product to provide two research-proven plant-based anti-inflammatories with high-potency curcumin and Aronia extract.

For athletes, inflammation is enemy # one. It delays recovery, increases risk for injury, and produces motivation-killing pain. Thus most athletes and a good percentage of regular exercisers, rely on NSAID’s (non-steroidal anti-inflammatory drugs) like aspirin, ibuprofen and naproxen. 

But chronic use of these drugs is associated with serious adverse side effects. A newer NSAID class, COX-2 inhibitors like Celebrex, were thought to reduce the number of adverse events, but instead brought new risks, and one (Vioxx) was banned after (according to the American Heart Association) causing more than 30,000 fatal heart attacks. 

The biochemist who formulated Joint Venture was part of a global research team that developed plant-based anti-inflammatory compounds, with safety and efficacy demonstrated in 11 published studies. These patented compounds – Univestin™ and Amlexin™ – are combined with other ingredients known to reduce inflammation and oxidative stress, improve joint comfort and range of motion. 

Each capsule provides:  

Hydrolyzed collagen 100 mg

Aronia berry concentrate 100 mg

Univestin   80 mg

Amlexin   80 mg

Curcumin (95% curcuminoids)   75 mg

NOTE:  Effective recovery and injury prevention can only be accomplished with attention to both sides of the metabolic see-saw. Reducing damage, and also stimulating repair. Two products that address this are CollaMacaVera and Synergized DHEA. 

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.